Concepedia

Author

Sunder Mudaliar

University of California San DiegoORCID

Also Known As

A. E. Kitabchi, A. Lyon, Dereck MaFong, Mudaliar Sunder, Mudaliar, Sunder R., R Henry, S Mudaliar, S R Mudaliar, S. Mudaliar, S. R. Mudaliar

170

Publications

15.4K

Citations

57

H-Index

98

Concepts

All Affiliations

University of California San DiegoVA San Diego Healthcare SystemPennington Biomedical Research CenterMedStar HealthThe University of Texas Health Science Center at San Antonio
SM

About

Sunder Mudaliar is an author at University of California San Diego specializing in medicine, metabolic syndrome, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

34

7.4K

2

Health Sciences

22

26

3.4K

3

Public Health

2

2

2.9K

4

Allergy

1

1

20

5

Applied Physiology

1

1

63

Sunder Mudaliar

×

96

Publications

13.7K

Citations

53

H-Index

YearCitations

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais,

The Lancet

2019

2.8K

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Frank L. Greenway, Ken Fujioka, Raymond A Plodkowski,

The Lancet

2010

991

Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal,

Gastroenterology

2013

906

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

Ralph A. DeFronzo, Devjit Tripathy, Dawn C. Schwenke,

New England Journal of Medicine

2011

729

Acute and Chronic Effect of Insulin on Leptin Production in Humans: Studies In Vivo and In Vitro

Jerzy W. Kolaczynski, Mark R. Nyce, Robert V. Considine,

Diabetes

1996

709

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais,

The Lancet

2019

600

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

Svetlana E. Nikoulina, Theodore P. Ciaraldi, Sunder Mudaliar,

Diabetes

2000

348

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

Sunder Mudaliar, Fedon Alexander Lindberg, M. Joyce,

Diabetes Care

1999

271

Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion

David Polidori, Sue Sha, Sunder Mudaliar,

Diabetes Care

2013

259

Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers

Robert R. Henry, Theodore P. Ciaraldi, Debra Armstrong,

The Journal of Clinical Endocrinology & Metabolism

2013

248

Page 1